About Cambrian Bioworks
Cambrian Bioworks is a company based in Bengaluru (India) founded in 2020 by Rohit Asil, Akshatha Ravi, and Raghav Pooviah Sridhar. It operates as a HealthTech and Direct-to-Consumer (D2C). Cambrian Bioworks has raised $1.45 million across 1 funding round from investors including Vaibhav Hegde and Irani family office. The company has 19 employees as of April 08, 2024. Cambrian Bioworks offers products and services including Manta, Beluga, and Eva.
- Headquarter Bengaluru, India
- Employees 19 as on 08 Apr, 2024
- Founders Rohit Asil, Akshatha Ravi, Raghav Pooviah Sridhar
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cambrian Biotech Pvt. Ltd.
- Date of Incorporation 15 Jun, 2020
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.45 M (USD)
in 1 rounds
-
Latest Funding Round
$1.45 M (USD), Seed
Aug 28, 2024
-
Investors
Irani family office
& 1 more
-
Employee Count
19
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cambrian Bioworks
Cambrian Bioworks offers a comprehensive portfolio of products and services, including Manta, Beluga, and Eva.
Efficient DNA/RNA extractions are provided for clinical applications.
Sample-to-result system is offered for seamless nucleic workflows.
Pathology workflows are enhanced with advanced diagnostic technology.
People of Cambrian Bioworks
Unlock access to complete
Unlock access to complete
Funding Insights of Cambrian Bioworks
Cambrian Bioworks has successfully raised a total of $1.45M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.45 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cambrian Bioworks
Cambrian Bioworks has secured backing from 2 investors, including angel and venture fund investors. Prominent investors backing the company include Vaibhav Hegde and Irani family office.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
VH
Vaibhav Hegde |
Angel investor and entrepreneur, focused on tech startups, ex-Amazon leader
|
Locked | Locked | Locked |
Investor details for Cambrian Bioworks
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cambrian Bioworks
Investment portfolio details for Cambrian Bioworks
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cambrian Bioworks
Detailed financials for Cambrian Bioworks
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cambrian Bioworks Comparisons
Peer comparison for Cambrian Bioworks
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cambrian Bioworks
Detailed competitors of Cambrian Bioworks
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cambrian Bioworks
Complete news archive for Cambrian Bioworks
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cambrian Bioworks
Cambrian Bioworks was founded in 2020 and raised its 1st funding round 4 years after it was founded.
Cambrian Bioworks is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Cambrian Bioworks is a funded company, having raised a total of $1.45M across 1 funding round to date.
As of Apr 08, 2024, the latest employee count at Cambrian Bioworks is 19.
Innovative technologies are built by Cambrian Bioworks to enable efficient and effective patient care. Focus is placed on advancing diagnostics across sectors like cancer, infectious diseases, genetic screening, and reproductive health. Solutions are provided for molecular workflows, including DNARNA extraction and digital microscopy, supporting labs globally from research to high-throughput facilities.
Cambrian Bioworks offers Manta, Beluga, and Eva.
Cambrian Bioworks has 2 investors. Key investors include Vaibhav Hegde, and Irani family office.